Placulumab clinical trials
Also written ART621.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How each study uses Placulumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2009 (2)
| Year | Studies |
|---|---|
| 2009 | 2 |
| 2011 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses Placulumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Study to Evaluate the Safety and Efficacy of Placulumab (CEP-37247) Administered by the Transforaminal Epidural Route for the Treatment of Patients With Lumbosacral Radicular Pain Associated With Disk HerniationCompletedPhase 1/2CephalonNCT01240876Written as CEP-37247
- Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking MethotrexateCompletedPhase 2Arana Therapeutics LtdNCT00854685Written as ART621
- Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking MethotrexateTerminatedPhase 2Arana Therapeutics LtdNCT00928317Written as ART621
Codes
What other systems call Placulumab · ClinicalTrials.gg INT017868
- UNII (FDA) S80W9W569LPLACULUMABConfirmed FDA, Wikidata
- Wikidata Q7200426PlaculumabConfirmed FDA, Wikidata
- NCI Thesaurus C170329PlaculumabOne source FDA
- DrugBank DB11983One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | S80W9W569L | PLACULUMAB | Confirmed FDA, Wikidata |
| Wikidata | Q7200426 | Placulumab | Confirmed FDA, Wikidata |
| NCI Thesaurus | C170329 | Placulumab | One source FDA |
| DrugBank | DB11983 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.